Biohaven acquires kv7 ion channel platform for the treatment of epilepsy and other neurologic disorders from channel biosciences, a subsidiary of knopp biosciences

New haven, conn., feb. 25, 2022 /prnewswire/ -- biohaven pharmaceutical holding company ltd.

BHVN Ratings Summary

BHVN Quant Ranking